| Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction … G Morton, M McGuffin, HT Chung, CL Tseng, J Helou, A Ravi, P Cheung, ... Radiotherapy and Oncology 146, 90-96, 2020 | 122 | 2020 |
| Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II … G Morton, HT Chung, M McGuffin, J Helou, L D’Alimonte, A Ravi, ... Radiotherapy and Oncology 122 (1), 87-92, 2017 | 91 | 2017 |
| Electromagnetic tracking for catheter reconstruction in ultrasound-guided high-dose-rate brachytherapy of the prostate S Bharat, C Kung, E Dehghan, A Ravi, N Venugopal, A Bonillas, ... Brachytherapy 13 (6), 640-650, 2014 | 72 | 2014 |
| System and method for magnetic occult lesion localization and imaging A Ravi, J Dillon US Patent 11,291,384, 2022 | 68 | 2022 |
| Evaluation of a machine-learning algorithm for treatment planning in prostate low-dose-rate brachytherapy A Nicolae, G Morton, H Chung, A Loblaw, S Jain, D Mitchell, L Lu, J Helou, ... International Journal of Radiation Oncology* Biology* Physics 97 (4), 822-829, 2017 | 68 | 2017 |
| Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial HC Quon, A Ong, P Cheung, W Chu, HT Chung, D Vesprini, A Chowdhury, ... Radiotherapy and Oncology 127 (2), 206-212, 2018 | 65 | 2018 |
| Doses to internal organs for various breast radiation techniques-implications on the risk of secondary cancers and cardiomyopathy JP Pignol, BM Keller, A Ravi Radiation oncology 6, 1-6, 2011 | 64 | 2011 |
| High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success J Helou, L D’Alimonte, A Loblaw, H Chung, P Cheung, E Szumacher, ... Radiotherapy and Oncology 115 (1), 84-89, 2015 | 63 | 2015 |
| Focal salvage high dose-rate brachytherapy for locally recurrent prostate cancer after primary radiation therapy failure: results from a prospective clinical trial J Murgic, G Morton, A Loblaw, L D'Alimonte, A Ravi, M Wronski, ... International Journal of Radiation Oncology* Biology* Physics 102 (3), 561-567, 2018 | 59 | 2018 |
| Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: Theoretical design DY Han, MJ Webster, DJ Scanderbeg, C Yashar, D Choi, B Song, S Devic, ... International Journal of Radiation Oncology* Biology* Physics 89 (3), 666-673, 2014 | 56 | 2014 |
| Volumetric changes of the anterolateral thigh free flap following adjuvant radiotherapy in total parotidectomy reconstruction KM Higgins, BM Erovic, A Ravi, R Yeung, JW Lee, C Yao, DJ Enepekides The Laryngoscope 122 (4), 767-772, 2012 | 52 | 2012 |
| Phase 1-2 study of stereotactic ablative radiotherapy including regional lymph node irradiation in patients with high-risk prostate cancer (SATURN): Early toxicity and quality … HB Musunuru, L D'Alimonte, M Davidson, L Ho, P Cheung, D Vesprini, ... International Journal of Radiation Oncology* Biology* Physics 102 (5), 1438-1447, 2018 | 50 | 2018 |
| Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities LC Mendez, Y Weiss, D D'Souza, A Ravi, L Barbera, E Leung Radiotherapy and Oncology 123 (2), 312-318, 2017 | 44 | 2017 |
| Permanent breast seed implant dosimetry quality assurance BM Keller, A Ravi, R Sankreacha, JP Pignol International Journal of Radiation Oncology* Biology* Physics 83 (1), 84-92, 2012 | 44 | 2012 |
| SABR in high-risk prostate cancer: outcomes from 2 prospective clinical trials with and without elective nodal irradiation Y Alayed, P Cheung, D Vesprini, S Liu, W Chu, H Chung, HB Musunuru, ... International Journal of Radiation Oncology* Biology* Physics 104 (1), 36-41, 2019 | 43 | 2019 |
| Pattern of relapse and dose received by the recurrent intraprostatic nodule in low-to intermediate-risk prostate cancer treated with single fraction 19 Gy high-dose-rate … LC Mendez, A Ravi, H Chung, CL Tseng, M Wronski, M Paudel, ... Brachytherapy 17 (2), 291-297, 2018 | 43 | 2018 |
| Clinical evaluation of an endorectal immobilization system for use in prostate hypofractionated Stereotactic Ablative Body Radiotherapy (SABR) A Nicolae, M Davidson, H Easton, J Helou, H Musunuru, A Loblaw, A Ravi Radiation oncology 10, 1-8, 2015 | 43 | 2015 |
| Predictive parameters of symptomatic hematochezia following 5-fraction gantry-based SABR in prostate cancer HB Musunuru, M Davidson, P Cheung, D Vesprini, S Liu, H Chung, ... International Journal of Radiation Oncology* Biology* Physics 94 (5), 1043-1051, 2016 | 41 | 2016 |
| Two StereoTactic ablative radiotherapy treatments for localized prostate cancer (2STAR): Results from a prospective clinical trial Y Alayed, P Cheung, W Chu, H Chung, M Davidson, A Ravi, J Helou, ... Radiotherapy and Oncology 135, 86-90, 2019 | 39 | 2019 |
| Direction modulated brachytherapy for treatment of cervical cancer. II: Comparative planning study with intracavitary and intracavitary–interstitial techniques DY Han, H Safigholi, A Soliman, A Ravi, E Leung, DJ Scanderbeg, Z Liu, ... International Journal of Radiation Oncology* Biology* Physics 96 (2), 440-448, 2016 | 39 | 2016 |
LoblawSunnybrook Health Sciences CentreVerified email at sunnybrook.ca
